Molecular Partners AG - stock earnings
MOLN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -12.5 million USD | 2.8 million USD |
| 2023Q2 | -17.8 million USD | 461625 USD |
| 2023Q1 | -16.8 million USD | 3.3 million USD |
| 2022Q4 | -21.5 million USD | 2.9 million USD |
| 2022Q3 | -12.3 million USD | 2.4 million USD |
| 2022Q2 | -2.8 million USD | 12.3 million USD |
| 2022Q1 | 165.5 million USD | 186.8 million USD |
| 2021Q4 | -19.6 million USD | 1.9 million USD |
| 2021Q3 | -13.2 million USD | 3.8 million USD |
| 2021Q2 | -18.4 million USD | 3.5 million USD |
| 2021Q1 | -17.5 million USD | 863325 USD |
| 2020Q4 | -24.0 million USD | 1.7 million USD |
| 2020Q3 | -17.9 million USD | 307388 USD |
| 2020Q2 | -16.6 million USD | 2.5 million USD |
| 2020Q1 | -16.3 million USD | 2.4 million USD |
| 2019Q4 | -9.4 million USD | 5.3 million USD |
| 2019Q3 | -9.2 million USD | 5.1 million USD |
| 2019Q2 | -9.3 million USD | 5.2 million USD |
| 2019Q1 | -9.1 million USD | 5.1 million USD |
| 2018Q4 | -9.4 million USD | 2.6 million USD |
| 2018Q3 | -9.5 million USD | 2.7 million USD |
| 2018Q2 | -9.3 million USD | 2.6 million USD |
| 2018Q1 | -9.7 million USD | 2.7 million USD |
| 2017Q4 | -6.5 million USD | 5.1 million USD |
| 2017Q3 | -6.6 million USD | 5.2 million USD |
| 2017Q2 | -6.7 million USD | 5.2 million USD |
| 2017Q1 | -6.4 million USD | 5.0 million USD |
| 2016Q4 | -4.6 million USD | 5.7 million USD |
| 2016Q3 | -4.8 million USD | 6.0 million USD |
| 2016Q2 | -4.8 million USD | 5.9 million USD |
| 2016Q1 | -4.8 million USD | 6.0 million USD |
| 2015Q4 | -37711 USD | 7.4 million USD |
| 2015Q3 | -38385 USD | 7.5 million USD |
| 2015Q2 | -40262 USD | 7.9 million USD |
| 2015Q1 | -38518 USD | 7.5 million USD |
| 2014Q4 | -577550 USD | 6.7 million USD |
| 2014Q3 | -600424 USD | 7.0 million USD |
| 2014Q2 | -640733 USD | 7.5 million USD |
| 2014Q1 | -643739 USD | 7.5 million USD |
| 2013Q4 | 2.0 million USD | 9.1 million USD |
| 2013Q3 | 2.0 million USD | 9.0 million USD |
| 2013Q2 | 1.9 million USD | 8.6 million USD |
| 2013Q1 | 1.9 million USD | 8.5 million USD |
MOLN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -70.9 million USD | 10.3 million USD |
| 2022 | 127.5 million USD | 205.0 million USD |
| 2021 | -69.9 million USD | 10.2 million USD |
| 2020 | -69.9 million USD | 10.4 million USD |
| 2019 | -37.5 million USD | 21.0 million USD |
| 2018 | -37.7 million USD | 10.5 million USD |
| 2017 | -26.0 million USD | 20.5 million USD |
| 2016 | -18.3 million USD | 22.6 million USD |
| 2015 | -150627 USD | 29.5 million USD |
| 2014 | -2.3 million USD | 26.9 million USD |
| 2013 | 8.0 million USD | 36.5 million USD |
MOLN
Price: $3.98
52 week price:
Earnings Per Share: -2.10 USD
P/E Ratio: -2.11
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 4126
Market Capitalization: 129.8 million